Tirofiban Hydrochloride I.V. Injection (5mg/100ml) Technical Specification: Product Name: Tirofiban Hydrochloride I.V. Injection Brand Name: Aggrixtaj Strength: (5mg/100ml or 50mcg/ml), (12.5mg/250ml or 50mcg/ml) Dosage Form: I.V. FSS Infusion Bottle (LVP) Packing: 100mL, 250mL IV FSS Bottle Route of Administration: For I.V. use only Pack Insert/Leaflet: PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) Regulatory Documents: […]
Tirofiban Hydrochloride I.V. Injection (12.5mg/250ml) Technical Specification: Product Name: Tirofiban Hydrochloride I.V. Injection Brand Name: Aggrixtaj Strength: (5mg/100ml or 50mcg/ml), (12.5mg/250ml or 50mcg/ml) Dosage Form: I.V. Infusion Bottle (LVP) Packing: 100mL, 250mL IV Bottle Route of Administration: For I.V. use only Pack Insert/Leaflet: PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) Regulatory Documents: COA, MOA, […]
Tirofiban Hydrochloride I.V. Injection (5mg/100ml) Technical Specification: Product Name: Tirofiban Hydrochloride I.V. Injection Brand Name: Aggrix – H Strength: 5mg/100ml Dosage Form: I.V. Infusion Glass Bottle (LVP) Packing: 100mL, 250mL IV Glass Bottle Route of Administration: For I.V. use only Pack Insert/Leaflet: PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) Regulatory Documents: COA, MOA, COPP, […]
Papaverine Hydrochloride Injection USP 30mg/ml Technical Specification: Product Name: Papaverine Hydrochloride Injection USP Brand Name: (GENERICS) Strength: 30mg/ml Dosage Form: Liquid Injection (Sterile) Packing: 10ml vial (Multiple-dose) Route of Administration: For I.V./I.M. Infusion ONLY Pack Insert/Leaflet: PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) Regulatory Documents: COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier […]
Nicardipine Hydrochloride Injection USP 25mg/10ml (2.5mg/ml) Technical Specification: Product Name: Nicardipine Hydrochloride Injection USP Brand Name: (GENERICS) Strength: 10mg/10ml (1mg/ml), 25mg/10ml (2.5mg/ml) Dosage Form: Liquid Injection (Sterile) Packing: 10ml Ampoules, Vial (single-dose) Route of Administration: For Intravenous Infusion Pack Insert/Leaflet: PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) Regulatory Documents: COA, MOA, COPP, FSC, Stability […]
Dobutamine Hydrochloride Injection USP 250mg/vial Technical specification: Product Name: Dobutamine Hydrochloride Injection USP Brand Name: (GENERICS) Strength: 250mg/vial Dosage Form: Dry Powder Injection (Lyophilized) Packing: 20ml vial Route of Administration: For I.V. Infusion after dilution only Pack Insert/Leaflet: PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) Regulatory Documents: COA, MOA, COPP, FSC, Stability Studies, GMP, […]
Recombinant Streptokinase for Injection BP 5,00,000 IU (0.5MIU) Technical Specification: Product Name: Recombinant Streptokinase for Injection BP Brand Name: Generic Strength: 15,00,000IU (1.5MIU), 7,50,000IU (0.75MIU), 2,50,000IU(0.25MIU), 5,00,000 IU (0.5MIU), 1,00,000 IU (0.1MIU) Dosage Form: Lyophilized Dry Powder Injection (Sterile) *Preservative Free *Albumin-free preparation Packing: 5ml Single Use Vial Route of Administration: For IV Use only […]
Recombinant Streptokinase for Injection BP 2,50,000IU(0.25MIU) Technical Specification: Product Name: Recombinant Streptokinase for Injection BP Brand Name: Generic Strength: 15,00,000IU (1.5MIU), 7,50,000IU (0.75MIU), 2,50,000IU(0.25MIU), 5,00,000 IU (0.5MIU), 1,00,000 IU (0.1MIU) Dosage Form: Lyophilized Dry Powder Injection (Sterile) *Preservative Free *Albumin-free preparation Packing: 5ml Single Use Vial Route of Administration: For IV Use only Pack Insert/Leaflet: […]
Recombinant Streptokinase for Injection BP 7,50,000IU (0.75MIU) Technical Specification: Product Name: Recombinant Streptokinase for Injection BP Brand Name: Generic Strength: 15,00,000IU (1.5MIU), 7,50,000IU (0.75MIU), 2,50,000IU(0.25MIU), 5,00,000 IU (0.5MIU), 1,00,000 IU (0.1MIU) Dosage Form: Lyophilized Dry Powder Injection (Sterile) *Preservative Free *Albumin-free preparation Packing: 5ml Single Use Vial Route of Administration: For IV Use only Pack […]
Recombinant Streptokinase for Injection BP 15,00,000IU (1.5MIU) Technical Specification: Product Name: Recombinant Streptokinase for Injection BP Brand Name: Generic Strength: 15,00,000IU (1.5MIU), 7,50,000IU (0.75MIU), 2,50,000IU(0.25MIU), 5,00,000 IU (0.5MIU), 1,00,000 IU (0.1MIU) Dosage Form: Lyophilized Dry Powder Injection (Sterile) *Preservative Free *Albumin-free preparation Packing: 5ml Single Use Vial Route of Administration: For IV Use only Pack […]
7July
2022
Each day is a brand-new opportunity for Taj Pharma Taj Pharmaceuticals has established itself as a top generic pharmaceutical company. With a product range that exceeds 4600 compositions across all therapeutic areas, it has successfully won the heart of consumers across the globe. The company is acclaimed as one of the top 10 pharmaceutical firms in India and the world’s leader in generics. Taj Pharma India is a market leader in therapeutic fields like Critaical care, transplantation, virology, and cancer. Taj Pharma’s generics and pharmaceuticals businesses work well together, and our knowledge of the bio-similar generic drugs enable us to create individualized therapeutic strategies and integrated healthcare solutions. The range of healthcare services and products offered by Taj Pharmaceutical includes genetic risk factor screening, disease diagnosis, disease prevention, treatment, and monitoring of the effectiveness of those treatments. Manufacturing of Lyophilized Products Taj Pharmaceuticals has spent the last ten years creating a brand-new category of healthcare organization. Building trust-based, long-lasting partnerships with Taj Pharma stakeholders is a goal shared by the whole Taj Pharma Group. This is clear in several ways. Through the discovery and development of cutting-edge, scientifically sound medications and services that enhance people’s health and general well-being worldwide, […]
16January
2022
Pharmaceutical firm Taj Pharma has announced that it has introduced Covid-19 treatment drug Molnupiravir under brand name “Molnutaj” in India. Molnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, drug maker said.
16July
2021
Today, Taj Pharma has 4000+ products approved by the FDA to manufacture. We have a highly independent regulatory team ready to assist and ensure the registration of your products of prescription drugs, controlled substances, biological products, medical supplies and food supplements to be available in the global market. Taj Pharmaceuticals been in the business for 30 years from drug manufacturing company, wholesale to distribution and exports that has given us a holistic view of the industry and now have established a good network of partners across the 7,641 agents across the world. Taj Pharma has partnered with more than 1,000 distributors including the leading pharmaceutical company in 42 countries to co-market our products to the top doctors form the most prestigious tertiary hospitals and medical center that prescribes the products we market among many global hospitals. To further advance our network, we are always present in global conventions, WHO submits and our products are also listed in CIIMS – MIMS and the Global Pharmaceutical Directories. To ensure our quality and branding, all our exported products are rigorously tested with our partner local laboratory accredited by FDA / CDSCO / NABL. With global published USP/BP/EP/IHS standards an external COA is issued which […]
14March
2020
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Coronavirus FAQs Coronavirus in India: how the 2019-nCoV could impact the world’s second–most populated country Coronavirus-affected countries: Italy Middle East South Korea Japan Singapore Malaysia China USA UK Thailand Philippines Latest on India coronavirus (Covid-19) situation, followed by details on states, union territories and cities. For latest coronavirus news updates, jump to NCR, Punjab, Tamil Nadu, Haryana, Telangana, Rajasthan, Uttar Pradesh, Karnataka, Bihar, Ladakh, Jammu and Kashmir, Andhra Pradesh, Maharashtra, Odisha, Himachal Pradesh, Mizoram, Kerala.
27December
2022
Pharmaceutical pricing authority discussed issue in 2019, show documents The shortage of key leprosy drug clofazimine in the country is not of recent origin, but a long-standing problem not properly addressed by the Union government, official documents show. clofazimine Minutes of a meeting of the National Pharmaceutical Pricing Authority (NPPA) under the Drug Pricing Control Order (DPCO), 2013 dated October 30, 2019 say Abbott Healthcare Private Limited has been directed not to discontinue the production of the drug as it could lead to shortages. DPCO is an order under the Essential Commodities Act, 1955 that enables the Union government to control and fix the prices of essential medicines and their formulations. The meeting discussed the Form-IV submitted by the company for the discontinuation of scheduled drug formulations Hansepran 50 mg (Clofazimine Capsule 50mg) and Hansepran 100 mg (Clofazimine Capsule 100mg) under para 21(2) of DPCO. “[The] authority considered the request of M/s Abbott Healthcare Pvt. Ltd and noted that [the] company has near monopoly (around 98% market share) for these critical medicines for leprosy and a sudden discontinuation could lead to shortages. It was therefore decided to direct the company to issue a public notice and continue production/import/sale for a […]
12September
2022
Presence in additional than 42 countries, we have a core goal to increase access to affordable high-quality medicines around the world Lyophilized Vials – With 2 technology Freeze Dryers/ Lyophilizers our annual production capability is four million vials (10 mL). Taj Pharmaceuticals is leading sterile manufacturing, excellent Lyophilized Injections technology and numerous delivery systems with 21 CFR 11 compliance. Taj Pharmaceuticals is a globally excellent vertically integrated pharmaceutical organization engaged within the development, producing and selling of high-quality Generic medication and prescription drugs formulations across various therapeutic areas. With a longtime presence in additional than 42 countries, we have a core goal to increase access to affordable high-quality medicines around the world. Headquartered in Mumbai, India, the Taj Pharma Group outreach the global markets through its flagship corporations – Taj PHARMA CIS LTD. Russia and Taj Pharma India Ltd. Taj Pharmaceuticals Ltd. Unit II Injections Manufacturing We are open for exploring business opportunities for South East Asian, Near East and CIS markets for in-licensing and out-licensing of finished product. Vision: To try towards developing and supporting healthy communities by improving the standard of life. Mission: To support groundbreaking solutions for major advancements & proportion inorder to attain sensible social and environmental impression Our […]
5September
2022
Ivermectin led to a 100% reduction in hospitalisation rate, a 92% reduction in mortality rate and an 86% reduction in the risk of dying from a COVID-19 infection BY WILL JONES 3 SEPTEMBER 2022 5:55 PM Regular use of ivermectin led to a 100% reduction in hospitalisation rate, a 92% reduction in mortality rate and an 86% reduction in the risk of dying from a COVID-19 infection when compared to non-users, a major new study has found. Ivermectin Tablets USP 12 mg (Iverotaj 12) The study, published in the medical journal Cureus, analysed data from 223,128 people from the city of Itajaí in Brazil and is the largest study of its kind, giving its findings a high degree of certainty. Senior author Dr. Flavio A. Cadegiani wrote on Twitter: “An observational study with the size and level of analysis as ours is hardly achieved and infeasible to be conducted as a randomised clinical trial. Conclusions are hard to be refuted. Data is data, regardless of your beliefs.” The study compared those who took ivermectin regularly, irregularly and not at all prior to being infected with COVID-19 (i.e., as prophylaxis), and found a dose-dependent relationship, confirming that the difference in outcomes is very likely to be due […]
28August
2022
We are exporting our WHO-GMP certified pharma manufacturing facilities product in Following Countries:- Benefits to the Pharmaceutical Industry in reviving through PCD Pharma Franchise Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, Iraq. African Countries: Nigeria, Tanzania, Sudan, Zambia, Benin, Angola, Liberia Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius. WHO-GMP certified pharma manufacturing facilities Regulatory Documents: Certificate of Analysis (COA)Method of Analysis (MOA)Stability Data (Accelerated stability / Long term stability / Zone 4b)CTD Dossier / ACTD Dossiers / eCTD DossiersCertificate of Pharmaceuticals Product (COPP)Free Sale Certificate (FSC) Leading WHO-GMP certified pharma manufacturing facilities Manufacturers, Suppliers in India Taj Pharmaceuticals, one of the leading WHO-GMP certified pharma manufacturing facilities Manufacturers India brings the best-quality products. The company carries the rich experience in the niche manufacturing of WHO-GMP certified pharma manufacturing facilities. Taj Pharmaceuticals is reputed manufacturer and WHO-GMP certified pharma manufacturing facilities suppliers in India prefer Taj Pharmaceuticals due to the reliability and purity of products. Taj Pharmaceuticals, the well-known WHO-GMP certified pharma […]
25March
2022
Potassium iodide is a salt of stable iodine, which is needed by the human body to produce thyroid hormones. Most of the iodine that people have in their bodies comes from the food they eat. However, radioactive iodine can be released into the air after a nuclear event, and inhaled into the lungs and then absorbed by the thyroid gland. Potassium iodide and iodine supplements work by blocking radioac Explained: Why Potassium Iodide Pills Are In Demand Since Ukraine War Began According to Centers for Disease Control, potassium iodide can help block radioactive iodine from being absorbed by the thyroid gland. The intensifying war in Ukraine has led to a surprising surge in the demand for potassium iodide pills. The fear of radioactive fallout from accidental or intentional attacks on Ukraine’s nuclear plants is the trigger behind the surge. If such an attack takes place, it will release radioactive iodine in the atmosphere, which can be absorbed by lungs or the thyroid glands. What is Potassium Iodide (KI)? Potassium Iodide Tablets USP 130 mg (TAJZOSAT) According to Centers for Disease Control (CC), potassium iodide (represented as KI) is a salt of stable iodine that can help block radioactive iodine from […]
10March
2022
Lyophilization or freeze drying is a process in which water is removed from a product after it is frozen and placed under a vacuum, allowing the ice to change directly from solid to vapor without passing through a liquid phase. The process consists of three separate, unique, and interdependent processes; freezing, primary drying (sublimation), and secondary drying (desorption). The advantages of lyophilization include:Ease of processing a liquid, which simplifies aseptic handlingEnhanced stability of a dry powderRemoval of water without excessive heating of the productEnhanced product stability in a dry stateRapid and easy dissolution of reconstituted productDisadvantages of lyophilization include:Increased handling and processing timeNeed for sterile diluent upon reconstitutionCost and complexity of equipment The lyophilization process generally includes the following steps: Dissolving the drug and excipients in a suitable solvent, generally water for injection (WFI).Sterilizing the bulk solution by passing it through a 0.22 micron bacteria-retentive filter.Filling into individual sterile containers and partially stoppering the containers under aseptic conditions.Transporting the partially stoppered containers to the lyophilizer and loading into the chamber under aseptic conditions.Freezing the solution by placing the partially stoppered containers on cooled shelves in a freeze-drying chamber or pre-freezing in another chamber.Applying a vacuum to the chamber and heating […]
12July
2021
Meta-analysis finds some ivermectin benefits in COVID-19 patient An analysis published in Open Forum Infectious Diseases found a 56% reduced risk of mortality for COVID-19 patients taking the anti-parasitic drug ivermectin compared to standard of care or another therapy. The study pulled data from 24 randomized trials involving 3,328 patients with moderate to severe COVID-19. Ivermectin tablets USP 12 mg (Iverotaj 12) The study also found that ivermectin was “associated with reduced inflammatory markers” and quicker viral clearance. Ivermectin, a widely available inexpensive drug used to treat worm and scabies infections in humans and animals, has emerged as a COVID-19 treatment in several parts of the world. Its use, however, has been controversial. WHO has counseled against its use as a COVID-19 treatment outside of clinical trials. And Merck, an ivermectin manufacturer, released a statement in February saying there was no scientific evidence to support the use of ivermectin for COVID-19. A study recently published in the American Journal of Therapeutics also found some benefits for ivermectin in treating COVID-19 with moderate-certainty evidence. The data from the study published in Open Forum Infectious Diseases is unlikely to convince skeptics. Nine of the studies involved in the meta-analysis were preprints. Another […]
11May
2021
Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans. Ivermectin Tablets USP 12 mg (Iverotaj 12) Source: https://doi.org/10.1016/j.antiviral.2020.104787 1. Introduction Ivermectin is an FDA-approved broad spectrum anti-parasitic agent (Gonzalez Canga et al., 2008) that in recent years we, along with other groups, have shown to have anti-viral activity against a broad range of viruses (Gotz et al., 2016; Lundberg et al., 2013; Tay et al., 2013; Wagstaff et al., 2012) in vitro. Originally identified as an inhibitor of interaction between the human immunodeficiency virus-1 (HIV-1) integrase protein (IN) and the importin (IMP) α/β1 heterodimer responsible for IN nuclear import (Wagstaff et al., 2011), Ivermectin has since been confirmed to inhibit IN nuclear import and HIV-1 replication (Wagstaff et al., 2012). Other actions of ivermectin have been reported (Mastrangelo […]
5May
2021
A new peer-reviewed study by Dr Pierre Kory and colleagues on Ivermectin has been published in the American Journal of Therapeutics. Entitled “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19“, it provides a new authoritative overview of the evidence to date and calls for the widely available drug to be “globally and systematically deployed in the prevention and treatment of COVID-19”. The study summarises the impressive evidence base for the use of Ivermectin. Ivermectin dispersible tablets 12mg Iverotaj D.T. 12 1. Since 2012, multiple in vitro studies have demonstrated that Ivermectin inhibits the replication of many viruses, including influenza, Zika, Dengue, and others.2. Ivermectin inhibits SARS-CoV-2 replication and binding to host tissue through several observed and proposed mechanisms.3. Ivermectin has potent anti-inflammatory properties with in vitro data demonstrating profound inhibition of both cytokine production and transcription of nuclear factor-κB (NF-κB), the most potent mediator of inflammation.4. Ivermectin significantly diminishes viral load and protects against organ damage in multiple animal models when infected with SARS-CoV-2 or similar coronaviruses.5. Ivermectin prevents transmission and development of COVID-19 disease in those exposed to infected patients.6. Ivermectin hastens recovery and prevents deterioration in patients with mild to […]
5May
2021
‘A combination of approved Ivermectin, Zinc and Doxycycline has shown positive results for COVID-19 and should be considered immediately to fight the pandemic’ Taj Covi Safe Kit Contains Zinc Acetate 50 mg, Doxycycline 100 mg & Ivermectin 12 mg Dispersible Tablets Australia’s The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody MB, BS, BSc(Med), MD, PhD, DSc, FRACP,FACP,FACG, AGAF, says FDA and TGA approved Ivermectin which he uses regularly in his hospital, has shown positive results for COVID-19 and should be considered immediately to fight the pandemic. Ivermectin was discovered in the 1970s and is on the World Health Organization (WHO) list of essential medicines. Professor Borody has used the same methodology with the COVID-19 Ivermectin Triple Therapy as he used when he developed the world’s first cure for peptic ulcers saving millions of lives around the globe. He says this combination of 3 approved “off the shelf” drugs could be the answer to Australia’s COVID-19 crisis. “If nothing else, make it available in aged care homes immediately. Our elderly are at the highest risk and this is a very safe option especially when we have nothing else except ventilators. Also, our frontline workers deserve more protection with a preventative […]
4May
2021
— Drug to be given to comatose Illinois patient after docs refusedby Jennifer Henderson, Enterprise & Investigative Writer, MedPage Today May 4, 2021 Ivermectin Tablets USP 12 mg (Iverotaj 12) An Illinois judge has ordered a hospital to give ivermectin to a comatose patient with few options left. Judge James Orel of DuPage County ordered Edward-Elmhurst Hospital to allow 68-year-old COVID-19 patient Nurije Fype to receive the drug, even though it isn’t endorsed by federal health agencies, the Chicago Tribune reported. Fox 32 Chicago reported that Fype, who has been in the intensive care unit since early last month and is currently on a ventilator, has since received her first dose. Her daughter, Desareta Fype, enlisted the help of a New York law firm that has taken on other ivermectin cases to force the hospital’s hand after none of its doctors would agree to administer the drug, according to the local media outlets. The Tribune reported Tuesday that an outside doctor was granted credentials at the hospital to administer the ivermectin. “‘Why wouldn’t this be tried if she’s not improving?’” the Tribune quoted Judge Orel as saying during a court hearing. “‘Why does the hospital object to providing this medication? […]
23April
2021
Taj Covi Safe Kit Contains Zinc Acetate 50 mg, Doxycycline 100 mg & Ivermectin 12 mg Dispersible Tablets. Taj Covi Safe Kit is currently indicated in the first line treatment for COVID-19 positive patients.
10April
2021
Remdesivir is considered as a key antiviral drug in the fight against COVID-19, especially in adult patients with severe complications The direction comes against reports of global shortages of the critical drug. Remdesivir is considered as a key antiviral drug in the fight against COVID-19, especially in adult patients with severe complications. The new wave came as a surprise after production was not continued as many countries were more focused on vaccination. The countries such as Venezuela has decided to procure remdesivir injections from Indian firms who can export, so that they could be provided treatment of critical COVID-19 patients from the economically weaker sections.
10July
2020
Taj Pharmaceuticals, one of the leading COVID -19 medicines Manufacturers India brings the best-quality products. The company carries the rich experience in the niche. Taj Pharmaceuticals is reputed manufacturer and COVID -19 medicines suppliers in India prefer Taj Pharmaceuticals due to the reliability and purity of products. Taj Pharmaceuticals, the well-known COVID -19 medicines Manufacturer in India gives the assurance of high-quality and purity. The stringent quality-control ensure that every batch of the drug brings a consistent standard. As COVID -19 medicines Exporters
16June
2020
Dexamethasone is a type of corticosteroid medication manufactured by Taj Pharmaceuticals India. It is used in the treatment of many conditions, including COVID-19 respiratory side effects, rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and along with antibiotics in tuberculosis. In adrenocortical insufficiency, it should be used together with a medication that has greater mineralocorticoid effects such as fludrocortisone. In preterm labor, it may be used to improve outcomes in the baby. It may be taken by mouth, as an injection into a muscle, or intravenously. The effects of dexamethasone are frequently seen within a day and last for about three days.
5June
2020
Important Tips To Boost Your Family’s Immunity Amid Coronavirus Outbreak, Eat Good; Look Good
5June
2020
Oseltamivir Phosphate Capsules 75 mg – Manufacturer in India, Taj Pharma Oseltamivir Phosphate Capsules Supplier, Oseltamivir Phosphate Capsules Exporter Taj Pharma | Oseltamivir phosphate capsules, Oseltamivir Phosphate capsules manufacturers, Oseltamivir suppliers, Oseltamivir exporters in India. Get contact details & address of company manufacturing Oseltamivir phosphate capsules
1June
2020
Coronavirus: Lockdowns in Europe saved millions of lives as per recent research
14May
2020
Myth busters: Coronavirus disease (COVID-19) awareness for the public
8May
2020
Most people have little control over when or whether they can — or have to — go back to work, as health officials, politicians, and companies make decisions about restarting the economy. But there are several steps many workers can take, particularly office workers, to reduce the risk of infection for themselves and co-workers when they do go back. These measures dovetail with preventive steps bosses and business owners can take in order to avoid fresh outbreaks and keep their workers safe.
6May
2020
Fun fact: Radish greens make greatpesto. Toss them in the blender with some oil and garlic and whatever nuts and/or cheese you can scrounge up and you’ve got yourself a killer sauce. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
6May
2020
In mid-March, when the reality of Covid-19 was setting in across the United States, alcohol sales soared. According to figures quoted by Bloomberg News, beer and wine sales surged 32% and 47%, respectively. Sales of hard liquor and cocktail mixes rose even more. Facing the prospect of extended stay-at-home restrictions, it seems that many Americans were in a hurry to stock their home bars and liquor cabinets.
1May
2020
A simple glossary of complicated and previously obscure words related to the pandemic. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
30April
2020
COVID-19 Taj Pharma CEO Generics Supply COVID-19 trials COVID-19 treatments Generics Supply Centers COVID-19 clinical trials coronavirus ongoing trials Coronavirus Cases in India breaking news updates on Coronavirus in India Coronavirus updates Latest Coronavirus News Coronavirus new cases outbreak of coronavirus disease (COVID-19)
29April
2020
#CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome
28April
2020
Full disclosure, I spend about 73% of my time obsessing about whether there will be summer camp in Rhode Island. I send borderline appropriate emails to people I work with on virus response, nagging them about this. CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
28April
2020
We have entered an age of social distancing. As we know, living as we do now slows the rise of the Covid-19 pandemic by reducing the number of interactions people have in a day, limiting the virus’ capacity to spread. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
27April
2020
Choirs are a secret lifeblood of our country. It’s unclear when and how we’ll ever sing together again. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
18April
2020
The WHO said there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected. The World Health Organization issued a warning Friday about coronavirus testing, saying there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected.
17April
2020
“The infection enigma,” explained. In the worst cases of Covid-19, the virus not only attacks and destroys tissue in the lungs but also triggers an overreaction of the immune system, creating dangerous levels of inflammation. Many of these patients are left unable to breathe on their own, and some die in hospital intensive care units, or at home.
16April
2020
Symptoms of the novel coronavirus can vary a lot, if an infected person experiences them at all. What are the signs you have been infected with the Covid-19 coronavirus? That’s become a surprisingly tricky question to answer, and it’s hampering the fight against the disease.
15April
2020
Scientists say a moonshot effort is needed to end social distancing and this pandemic. Will leaders listen? The failures of the United States’ initial response to the Covid-19 pandemic are already well established: Officials were too slow to recognize the threat of the disease and too slow to get diagnostic testing in place, and were ill prepared for the strain on our health care system.
15April
2020
We need to find out who has the antibodies to the virus. Testing to see who has the Covid-19 coronavirus has become one of the most crucial elements of slowing the global pandemic. And it may also hold the key to a return to normal.
14April
2020
Covid-19’s duration varies widely depending on severity, but now we know the rough range. In the early weeks of the Covid-19 crisis, little was known about the wide range of possible symptoms and the typical progression of the disease. Now, more than three months into the coronavirus outbreaks, doctors and researchers are finally getting a handle on the typical duration of the illness and how it plays out.
14April
2020
What to do if you suspect you might have Covid-19. COVID-19 is a rapidly spreading disease, caused by a coronavirus that jumped from animals to humans in late 2019. Here are the most pressing and recent questions related to the fast-moving pandemic. Coronavirus: What are the symptoms of Covid-19? How to seek medical advice, explained
10April
2020
A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
9April
2020
The FDA has approved an abbreviated new drug application for hydroxychloroquine sulfate tablets to address ongoing shortages of the drug sparked by its still unproven potential as a COVID-19 treatment.
9April
2020
The latest on the potential Covid-19 treatment under research. A daily Covid-19 update from {Taj Pharmaceuticals Limited} Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
8April
2020
Even as hospitals and governors raise the alarm about a shortage of ventilators, some critical care physicians are questioning the widespread use of the breathing machines for Covid-19 patients, saying that large numbers of patients could instead be treated with less intensive respiratory support. A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
7April
2020
Last week, the Centers for Disease Control and Prevention issued new face-mask guidance, encouraging everyone to wear cloth face coverings when in public. The reasoning: “We now know from recent studies that a significant portion of individuals with coronavirus lack symptoms,” and that those individuals can transmit the virus to others. Covid-19 hotspot, Coronavirus Live, Covid-19 state-wise Cases, Coronavirus cases in India, Dharavi Covid-19 cases, Covid-19 Cases, Covid-19, Covid-19 Lockdown, Covid-19 update
7April
2020
{Taj Pharmaceuticals Ltd} Hydroxychloroquine Sulfate for treatment of COVID-19 Patients, Strategic Plan for Positive Market Research- 2030
4April
2020
Clinical trials will test if antibodies against the coronavirus prevent infection, aid survival. A patient in Beijing who has recovered from COVID-19 donates plasma, the liquid part of blood, which contains antibodies against the coronavirus.
4April
2020
Developing a Vaccine with New Technology Around 10 January, Chinese scientists developed and shared a full genetic sequence of SARS-Cov2, the virus that causes COVID-19, colloquially called coronavirus. Several companies are using this information to develop vaccines that will contain a small amount of genetic code. Certain cells in the body will take up this genetic information and produce elements of the virus, not infecting the person but triggering the immune system to respond. DNA or RNA based vaccines are not made with a weakened or deactivated virus, nor elements of the virus, so they can be produced in the lab. This approach is faster and more reliable than traditional vaccine processing, which uses virus grown in eggs or cell cultures. For example, Moderna, in collaboration with the National Institute of Allergy and Infectious Disease (USA), developed the first COVID-19 vaccine in clinical trials using a genetic platform called messenger RNA (mRNA). It took only 42 days to move from vaccine design to human testing – an industry record. While genetic platforms are promising and fast, there are currently no such vaccines approved for human use. In addition to the many companies pursuing vaccines on this platform, other companies are […]
3April
2020
Research has emerged suggesting coronavirus survivors’ plasma could save lives; Scientists are in disagreement over whether the virus is airborne or not; A study also suggests that cats can contract the virus and transmit it to other cats.
3April
2020
‘No one has a real idea of what the total demand is likely to be before the epidemic ends’ “Close the borders! Ground the planes!” Such responses are natural and understandable, but, taken too far, may become counterproductive. Social distancing for individuals is an unfortunate necessity; for countries, the reflex threatens to turn into a terrible policy. The same hoarding impulse to take care of your own, which has led to unnecessarily empty toilet paper shelves all over the world, may exacerbate a far more serious shortage: getting ventilators to the people who need them.
3April
2020
It’s complicated … most vaccines used today took between 5-15 years to perfect. Time to get a COVID-19 vaccine to market is likely to be at least 18 months.Potential treatments require testing and funding.International organizations are helping to fund research. COVID-19 is new and scientists understand little about how it behaves and spreads. The cost of creating a vaccine to protect people against the new coronavirus will run into billions of dollars and could take many months. Here are some of the reasons why. COVID-19 Vaccines are complex to make Technology is enabling new methods of exploring vaccine candidates for trial, but there are already a few tried and tested ways to make them. In all of them, scientists try to stimulate the body’s immune system to combat invasive pathogens. That’s commonly done by creating something so similar to the pathogen that the body begins to create antibodies to fight off the real thing. The most common way of doing this is to make what’s called attenuated vaccines – those that are made of weaker strains of the actual pathogen. Reared on animal cells outside of human bodies (some flu vaccines are cultured on chicken eggs), they are then extracted […]
![[Taj Pharma Mumbai] Supporting older people during the COVID-19 pandemic is everyone’s business](https://tajpharma.in/wp-content/uploads/cache/images/Taj-Pharma-India-Supporting-older-people-during-the-COVID-19-pandemic-is-everyone’s-business/Taj-Pharma-India-Supporting-older-people-during-the-COVID-19-pandemic-is-everyone’s-business-768913808.jpg)
3April
2020
[Taj Pharma Mumbai] Supporting older people during the COVID-19 pandemic is everyone’s business
3April
2020
How to go for a run or a walk without making it a health risk.The coronavirus pandemic has forced millions to stay inside in an effort to flatten the curve. But even under stay-at-home orders, people can go outside to exercise, as long as they stay six feet away from others.
3April
2020
In the news today: the world passed 1 million cases of Coronavirus. A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
2April
2020
How the coronavirus travels through the air has become one of the most divisive debates in this pandemic. A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
2April
2020
What the experts say? A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
1April
2020
With concerns rising about medicine availability during the global COVID-19 coronavirus pandemic, European Pharmaceutical Review explores how the pharmaceutical supply chain is faring
30March
2020
Masks, and other much needed medical equipment, are in short supply all across the world.Ventilators for patients with severe cases of COVID-19 are in short supply globally. The new coronavirus has infected more than half a million people worldwide. Companies including Dyson and Ford Motor Company are stepping up to meet the demand for ventilators, alongside other innovations.
29March
2020
A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
28March
2020
Local data simply isn’t available, while state and national totals woefully underreport the reality. A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
28March
2020
The medical research community is collaborating in unprecedented ways, and working overtime, to fight COVID-19. Academics, public health agencies, biotech, and big pharma are working together to repurpose existing drugs, develop new therapies and protect us with new vaccines. What can we expect them to deliver — and when?
28March
2020
The test can run on small machines the size of a toaster; A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
27March
2020
Brands are pivoting to make cloth masks, but if they don’t have HEPA filters inside them, they can’t keep virus particles out of your mouth
24March
2020
The growing outbreak of COVID-19 has affected each one of us in multiple ways, our families, friends, businesses and way of life. This fast-changing situation has forced us to re-evaluate how we operate. At Taj Pharmaceuticals, we are working on using this challenge as an opportunity to make our company more dedicated, more efficient, and more focused on serving the needs of our clients, a better company to partner with in our common mission of bringing healthcare treatments to market faster and of improving outcomes for patients. COVID-19, Taj Pharma CEO, Generics Supply, COVID-19 trials, COVID-19 treatments, Generics Supply Centers, COVID-19 clinical trials, coronavirus ongoing trials
23March
2020
More than 350,000 people have tested positive for the COVID-19 novel coronavirus around the world, with confirmed positives surging as testing becomes more widespread. More than 15,000 people have died due to complications from the virus.
21March
2020
As the novel coronavirus (COVID-19) situation continues to evolve and business impacts are becoming more far reaching across every sector, I wanted to share what we are doing at Taj Pharmaceuticals to ensure the continuity in our support of you and the people in your care. Read more
![{Taj Pharmaceuticals Ltd.} [Latest generic drug news] What’s the difference between a cold and the flu](https://tajpharma.in/wp-content/uploads/cache/images/Taj-Pharmaceuticals-Ltd_-Latest-generic-drug-news-What’s-the-difference-between-a-cold-and-the-flu/Taj-Pharmaceuticals-Ltd_-Latest-generic-drug-news-What’s-the-difference-between-a-cold-and-the-flu-4045868799.jpg)
20March
2020
{Taj Pharmaceuticals Ltd} [Latest generic drug news] What’s the difference between a cold and the flu The common cold and the flu may seem similar at first. They’re both respiratory illnesses and can cause similar symptoms. But different viruses cause these two conditions. Your symptoms help you tell the difference between them. Both a cold and the flu share a few common symptoms. People with either illness often experience: As a rule, flu symptoms are more severe than cold symptoms. Another distinct difference between the two is how serious they are. Colds rarely cause other health conditions or problems. But the flu can lead to sinus and ear infections, pneumonia, and sepsis. To determine whether your symptoms are from a cold or from the flu, you need to see your doctor. Your doctor will run tests that can help determine what’s behind your symptoms. If your doctor diagnoses a cold, you’ll only need to treat your symptoms until the virus has run its course. These treatments can include using over-the-counter (OTC) cold medications, staying hydrated, and getting plenty of rest. Taking flu medicine early in the virus’ cycle may help reduce severity of illness and shorten the time that you […]
19March
2020
Taj Pharmaceuticals Biotechnological Division has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April.
19March
2020
We Taj Pharmaceuticals are in the midst of challenging times, brought upon us due to the unimaginable spread of COVID-19. As we grapple with this difficult and ever evolving situation, we wanted to reach out to make sure that you are doing okay and in case you needed any help. It is hard to think of a business that is not impacted by this pandemic, the effects of which we will all continue to feel for a long time. Considering the current situation across the globe wherein everyone is trying their best to tackle the Coronavirus pandemic, we understand that we aren’t insulated from any uncertainties too. We, as an organisation, are doing our bit to ensure the safety and security of our employees, partners, etc. while ensuring that the work isn’t hampered. coronavirus As a firm, we have always placed the highest emphasis on delivering quality generics to all our clients, consistently. I want to take this opportunity to assure you that our professional commitments continue to occupy an important place for all of us at Taj Pharmaceuticals even as we steer our way through the crisis. Our Values of Care and Working Together come to fore in difficult […]
18March
2020
{Taj Pharma India} How the coronavirus (COVID-19) test works
17March
2020
Every country needs to take boldest actions to stop COVID-19
16March
2020
Combining carbs and sweeteners could affect insulin sensitivity :{Taj Life Sciences} Eat good; Look good
14March
2020
India reported the first confirmed case of the coronavirus infection on 30 January 2020 in the state of Kerala. The affected had a travel history from Wuhan, China.
![Coronavirus outbreak shows Asia needs to step up infection preparation [Taj Pharma]](https://tajpharma.in/wp-content/uploads/cache/images/Coronavirus-outbreak-shows-Asia-needs-to-step-up-infection-preparation-Taj-Pharma-taj/Coronavirus-outbreak-shows-Asia-needs-to-step-up-infection-preparation-Taj-Pharma-taj-1459919982.jpg)
11March
2020
Coronavirus outbreak shows Asia needs to step up infection preparation [Taj Pharma]
2March
2020
This is how HIV decides to become active Researchers have found the molecular mechanism underpinning HIV’s decision to remain in an active or dormant state. This may lead to new therapies that work by keeping the virus in a permanently dormant state. The study, led by a team from the Gladstone Institutes in San Francisco, CA, features in a paper now published in the journal Cell. The findings may also explain cell fate decisions that occur elsewhere in biology — such as how stem cells decide whether to remain as stem cells or differentiate into specialized cells, including brain or heart cells, when they divide. Senior study author Prof. Leor S. Weinberger, the director of the Center for Cell Circuitry at the Gladstone Institutes, likens the process to how we “hedge our bets” when we make decisions about financial investments. To “protect against volatility in the market,” we may choose to place some funds in high-risk stocks with potentially high yields and the rest in low-risk, low-yield options. “Similarly,” he explains, “HIV covers its bases in a volatile environment by generating both active and dormant infections.” HIV latent reservoir: Once it enters the human body, HIV inserts its genetic material […]
29February
2020
{Taj Pharma Cancer Awareness Initiative} Genetic ‘fingerprints’ implicate gut bacterium in bowel cancer
27February
2020
The making of a living ovarian cancer biobank
17February
2020
Online mindfulness-based cognitive therapy to improve lingering depression: {Taj Pharmaceuticals}
12February
2020
Here’s the timeline of how the Coronavirus outbreak evolved from Wuhan city in China and spreading its tentacles across the world. Update: DBS evacuates 300 after one is infected – Singapore’s DBS bank has evacuated 300 employees after one employee was confirmed to have contracted the coronavirus. Japan cruise cases increase to 174 – The total confirmed cases on the Diamond Princess cruise ship, quarantined in Japan, have surged to 174. Death toll reaches 1,115; recoveries rise – Deaths from the new coronavirus have reached 1,115, while the total number of cases exceeded 45,100, including 44,653 reported in mainland China by authorities as of the end of 11 February. – According to NHC official Mi Feng, the proportion of recovered patients in China increased to 8.2% as of 10 February, from 1.3% on 27 January. WHO gives name to new coronavirus disease – The WHO has officially named the disease caused by the new coronavirus as ‘Covid-19’. – Ukraine is screening five of its citizens for the novel coronavirus, Health Minister Zoriana Skaletska said at a press briefing on 11 February. – According to Skaletska, three of the five suspected patients returned from China while the remaining two were in […]
12February
2020
WHO officially names new coronavirus disease Covid-19 The World Health Organization (WHO) has officially named the disease caused by the new coronavirus, initially identified in Wuhan, China, as Covid-19.
![How can I lose weight by {Taj Pharmaceuticals} [India’s Top Generic Giant]](https://tajpharma.in/wp-content/uploads/cache/images/How-can-I-lose-weight-by-Taj-Pharmaceuticals-India’s-Top-Generic-Giant/How-can-I-lose-weight-by-Taj-Pharmaceuticals-India’s-Top-Generic-Giant-4106394344.jpg)
10February
2020
How can I lose weight by {Taj Pharmaceuticals} [India’s Top Generic Giant]
30January
2020
Never too late to quit: protective cells could cut risk of lung cancer for ex-smokers {Taj Pharma}
27January
2020
China coronavirus: All you need to know – A new virus has killed 81 people in China and infected almost 3,000 people, with cases confirmed in several countries. Coronavirus: Everything you need to know Health authorities around the world are grappling with an outbreak of a new coronavirus, which originated in the Chinese city of Wuhan. At least 81 people have died in China and almost 3,000 have been infected worldwide. What is a coronavirus? Coronaviruses are a large family of viruses that cause illnesses ranging from the common cold to more severe diseases such as Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), according to the World Health Organization (WHO). They circulate in animals and some can be transmitted between animals and humans. Several known coronaviruses are circulating in animals that have not yet infected humans. The new coronavirus has been named novel coronavirus (2019-nCoV). It is the seventh coronavirus known to affect humans. What are the symptoms? Common signs of infection include fever, coughing and breathing difficulties. In more severe cases, infection can cause pneumonia, SARS, kidney failure and death. The incubation period of the new coronavirus is thought to be between one and 14 […]
27January
2020
Researchers have found that men and women with major depression have opposing changes in gene expression.
27January
2020
What is melanoma? | Melanoma Stages | Melanoma Types | Melanoma Risk factors | Melanoma Symptoms | Melanoma Treatment | Prevention melanoma | Melanoma Diagnosis | Melanoma Outlook Melanoma is a type of skin cancer. It is not the most common, but it is the most serious, as it often spreads. When this happens, it can be difficult to treat, and the outlook may be poor. Risk factors for melanoma include overexposure to the sun, having fair skin, and a family history of melanoma, among others. melanoma Receiving an early diagnosis and getting prompt treatment can improve the outlook for people with melanoma. For this reason, people should keep track of any changing or growing moles. Using adequate protection against sun exposure can help a person prevent melanoma altogether. This article covers the symptoms of melanoma, how a doctor would diagnose it, and ways to treat it. We also explain how best to prevent melanoma. What is melanoma? A person may be more at risk of melanoma if they have a family history of the condition. Melanoma is a type of skin cancer that occurs when pigment producing cells called melanocytes mutate and begin to divide uncontrollably. Most pigment cells […]
27January
2020
The symptoms of frontotemporal, or early onset, dementia can appear as early as age 40. Have researchers found a new way to treat this condition using antibiotics?
![Immunotherapy comparable to chemo for some advanced stomach cancers [Taj Pharma Global Cancer initiative]](https://tajpharma.in/wp-content/uploads/cache/images/Immunotherapy-comparable-to-chemo-for-some-advanced-stomach-cancers-Taj-Pharma-Global-Cancer-initiative/Immunotherapy-comparable-to-chemo-for-some-advanced-stomach-cancers-Taj-Pharma-Global-Cancer-initiative-2308906734.jpg)
23January
2020
Immunotherapy comparable to chemo for some advanced stomach cancers [Taj Pharma Global Cancer initiative]
23January
2020
Magnetised molecules used to monitor breast cancer {Taj Pharmaceuticals} [Mumbai Chronicle]
22January
2020
{Taj Pharma} Why do some cancers metastasise, but others don’t?
16January
2020
Radiation therapy | Immunotherapy | Hormone therapy | Targeted therapy | Making a decision | Outlook | Takeaway Doctors use chemotherapy either as a first-line therapy or in combination with other treatments, such as surgery. If chemotherapy does not work, a person may need to consider other treatment options.
16January
2020
Diabetes | Diabetes Causes | Diabetes Diagnosis | Diabetes Outlook | Diabetes Risk factors | Diabetes Symptoms | Diabetes Treatment and prevention | Diabetes Type 1 | Diabetes Type 2 | type 2 diabetes | types 1 Diabetes
15January
2020
Does the ketogenic diet work for type 2 diabetes? The ketogenic diet and diabetes Side effects Alternatives Criticisms Outlook
15January
2020
Researchers have zoomed in on the fine molecular and epigenetic mechanisms that explain the aggressive spread of melanoma. Scientists examine the epigenetic silencing of circRNA and how this drives the spread of melanoma. Along with DNA and proteins, RNA is one of the three essential macromolecules necessary for all forms of life. The typical process at the basis of all known forms of life comprises three steps: The genetic information from our DNA — which works as the “blueprint” of the cell — is converted into an RNA “photocopy,” which, in turn, helps create proteins required by the cell. Most RNA is in linear form. However, some RNA molecules are circular. These are called circular RNAs (circRNA). Linear RNA encodes proteins, but very few circRNAs have clearly understood functions. In fact, the medical community is only now beginning to elucidate the contribution of circRNA to normal physiology and disease, write the authors of a new paper. So, what is the role of circRNAs in the spread of melanoma? Senior study author Eva Hernando, Ph.D. — an associate professor in the Department of Pathology at New York University (NYU) Langone Health — and colleagues set out to investigate. The question is […]
15January
2020
Dead bodies are revealing the secrets of how cancer kills : {Taj Pharmaceuticals}
13January
2020
Kids born with assisted reproduction are not at higher risk of getting cancer Recently, Allison and Honjo have been awarded with the Nobel prize for their findings leading to the new cancer treatment approaches known as immune checkpoint inhibitors (ICIs). Thanks to these discoveries in fact, the management of the disease has profoundly changed, producing remarkable results on several tumors, even if checkpoint inhibitors have significant side effects, that according to an analysis published in Jama are still poorly known by many health professionals. It is “urgent”, according to authors, “to identify who is at highest risk of severe outcomes, and then develop evidence-based therapies to manage toxicity”. Understanding these adverse effects is essential not for oncologist only, but for every physician in any discipline, as said by Douglas B. Johnson, MD, of Vanderbilt University, Nashville, Tennessee, and colleagues. Indeed, they underlined what are the most common effects which occur in practice in an article published online in JAMA. Many organs can be involved, commonly the skin, the gastrointestinal tract, the lungs, endocrine organs, musculoskeletal, renal, nervous, hematologic, cardiovascular, and ocular systems, thus counting such side effects as a problem to be faced jointly among the various physicians. Autoimmune events are […]
13January
2020
World Oncology Forum articulates the case for investing in affordable cancer care
11January
2020
Despite more than a decade of efforts to address the problem, cancer patients across Europe and the US still cannot rely on essential drugs being available when they need them. Rachel Brazil looks at the size of the problem, its impact on patients and professionals, and the efforts to put in place policies and alternative business models that could offer a solution. For the last decade, headline stories about problems accessing cancer drugs have focused almost exclusively on novel ‘targeted’ treatments. Less publicised is the story of growing problems accessing traditional cytotoxics and other oncology medicines that are no longer on patent, but remain the real workhorses of oncology care across most cancer types. Health services have traditionally relied on the generics market to provide affordable copies of brand-name drugs once the patent that gives market exclusivity has expired. But a persistent problem of re-occurring shortages across a wide range of generics is damaging patient outcomes, adding to the workloads of hospital pharmacists and others in the care team, and raising questions about how to balance the need for competition against the requirement of a guaranteed supply line. Whilst the problem is not unique to oncology, shortages of generic drugs […]
11January
2020
The crisis in access to essential medicines in India: key issues which call for action Author: Anurag Bhargava, SP Kalantri | DOI: https://doi.org/10.20529/IJME.2013.028 Abstract The government is planning to introduce free generic and essential medicines in public health facilities. Most people in India buy healthcare from the private sector, a compulsion that accounts for a high proportion of healthcare-related expenditure. To reduce the burden of healthcare costs, the government must improve availability and affordability of generic and essential medicines in the market. It can do so because India’s large pharmaceutical industry is a major source of generic medicines worldwide. In this article, we discuss three factors that have impeded access to generic and essential medicines: mistaken notions among policymakers, prescribers and patients about branded drugs and generic drugs in India; high prices of medicines due to the progressive dismantling of the system of regulation of medicine prices, and a drug approval and regulatory system that allows medicines (including fixed dose combinations) of doubtful efficacy, rationale, safety and public health relevance to dominate the market at the cost of access to affordable generic and essential medicines. The consequences of ill-health and wasted expenditure on drugs raise issues of public health ethics. […]
11January
2020
Half of pediatric cancers undiagnosed and untreated worldwide Nearly one in two children with cancer are never diagnosed and may die untreated, according to a a new model proposed in a study published in The Lancet Oncology by Zachary Ward and colleagues from Harvard University T.H. Chan School of Public Health. In fact, the model estimates that there were 397.000 childhood cancer cases globally in 2015, while only 224,000 had been previously recorded as diagnosed that year, leading ultimately the researchers to say that over 43% of childhood cancer cases were undiagnosed. But there was substantial regional variation: it ranges from 3% in both Western Europe (120 undiagnosed cases out of 4,300 total new cases) and North America (300 of 10,900 cases), to 57% (43,000 of 76,000 new cases) in Western Africa. With such path, at current levels of health system performances, If no improvements are made, the study authors estimated that nearly three million out of 6.7 million total cases will be missed between 2015 and 2030. Accounting for underestimation is vital: accurate estimates of incidence are important for policy makers, however, many countries do not have cancer registries that quantify that incidence (and often even if they do […]
7January
2020
Global Call To Action on Familial Hypercholesterolemia: Aims to Improve Diagnosis and Treatment Worldwide The FH Foundation and the World Heart Federation announced today a Global Call to Action on familial hypercholesterolemia (FH), a vastly under-recognized and poorly managed public health concern. Published in JAMA Cardiology and authored by a global panel of scientific experts, advocacy leaders, public health officials, and individuals with FH from 40 countries, the report notes glaring gaps in screening and guideline-based care for FH, the most common cause of early and aggressive heart disease. FH is an inherited metabolic disorder found in all races and ethnicities and impacts 34 million people worldwide. FH causes high LDL-cholesterol from birth and should be diagnosed and treated within the first two decades of life. Left untreated, individuals with FH have a 20-times higher risk of illness and death from cardiovascular disease (CVD). However, if diagnosed and treated, heart attacks, strokes and the need for surgery can be prevented. The international coalition was convened by the FH Foundation and World Heart Federation to reexamine and update key recommendations issued by the World Health Organization (WHO) in their report on Familial Hypercholesterolemia in 1998. In the 20 years since that report, […]
